中文版 | English
题名

PPM Ir-f-phamidol-Catalyzed Asymmetric Hydrogenation of γ-Amino Ketones Followed by Stereoselective Cyclization for Construction of Chiral 2-Aryl-pyrrolidine Pharmacophores

作者
通讯作者Bai, Shao-Tao; Lang, Qiwei; Zhang, Xumu
发表日期
2023
DOI
发表期刊
ISSN
0022-3263
EISSN
1520-6904
卷号89期号:1页码:527-533
摘要
Transition metal catalysts with a million turnovers and excellent selectivity are rarely reported but are crucial for the industrial manufacture of optical pure pharmaceuticals, natural products, and fine chemicals. In this paper, we report an unprecedented aninoic Ir-f-phamidol catalyst for asymmetric hydrogenation of γ-amino ketones followed by stereoselective cyclization for construction of valuable chiral 2-aryl-pyrrolidine pharmacophores. The Ir-f-phamidol catalyst showed up to 1,000,000 TON and >99% ee, as well as excellent tolerance of substrates and protecting groups, providing various chiral amino alcohol intermediates. Upon optimization of the conditions, the stereoselective cyclization reaction was highly smooth and efficient (quantitative conversions, 92 to >99% ee). Finally, this solution was applied in the preparation of high-value chiral entities containing such chiral 2-aryl-pyrrolidine pharmacophores.
© 2023 American Chemical Society
相关链接[Scopus记录]
收录类别
EI ; SCI
语种
英语
学校署名
第一 ; 通讯
资助项目
This work was supported by the National Natural Science Foundation of China (21991113), National Key R&D Program of China (2021YFA1500200, 2021YFA0910804), Guangdong Basic and Applied Basic Research Foundation (2021A1515110808), the Research Projects of Department of Education of Guangdong Province (2023ZDZX000), the Scientific Research Startup Fund for Shenzhen High-Caliber Personnel of SZPT (6023330003K), and Shenzhen Humanities & Social Sciences Key Research Bases.
出版者
EI入藏号
20240115312795
EI主题词
Catalyst selectivity ; Cyclization ; Hydrogenation ; Industrial chemicals ; Pharmacodynamics ; Stereoselectivity ; Transition metals
EI分类号
Medicine and Pharmacology:461.6 ; Metallurgy and Metallography:531 ; Chemistry:801 ; Chemical Reactions:802.2 ; Chemical Agents and Basic Industrial Chemicals:803 ; Chemical Products Generally:804 ; Organic Compounds:804.1
ESI学科分类
CHEMISTRY
Scopus记录号
2-s2.0-85181037261
来源库
EV Compendex
引用统计
被引频次[WOS]:1
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/673959
专题理学院_化学系
作者单位
1.Department of Chemistry and Department of Chemistry and Medi-X PingShan, Southern University of Science and Technology, Shenzhen; 518055, China
2.Center for Carbon-Neutrality Catalysis and Engineering and Institute of Carbon-Neutral Technology, Shenzhen Polytechnic University, Shenzhen; 518055, China
3.Research Center of Green Pharmaceutical Technology and Process, Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang; 443002, China
第一作者单位化学系
通讯作者单位化学系
第一作者的第一单位化学系
推荐引用方式
GB/T 7714
Yin, Congcong,Zhang, Runtong,Pan, Yingmin,et al. PPM Ir-f-phamidol-Catalyzed Asymmetric Hydrogenation of γ-Amino Ketones Followed by Stereoselective Cyclization for Construction of Chiral 2-Aryl-pyrrolidine Pharmacophores[J]. Journal of Organic Chemistry,2023,89(1):527-533.
APA
Yin, Congcong.,Zhang, Runtong.,Pan, Yingmin.,Gao, Shuang.,Ding, Xiaobing.,...&Zhang, Xumu.(2023).PPM Ir-f-phamidol-Catalyzed Asymmetric Hydrogenation of γ-Amino Ketones Followed by Stereoselective Cyclization for Construction of Chiral 2-Aryl-pyrrolidine Pharmacophores.Journal of Organic Chemistry,89(1),527-533.
MLA
Yin, Congcong,et al."PPM Ir-f-phamidol-Catalyzed Asymmetric Hydrogenation of γ-Amino Ketones Followed by Stereoselective Cyclization for Construction of Chiral 2-Aryl-pyrrolidine Pharmacophores".Journal of Organic Chemistry 89.1(2023):527-533.
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Yin, Congcong]的文章
[Zhang, Runtong]的文章
[Pan, Yingmin]的文章
百度学术
百度学术中相似的文章
[Yin, Congcong]的文章
[Zhang, Runtong]的文章
[Pan, Yingmin]的文章
必应学术
必应学术中相似的文章
[Yin, Congcong]的文章
[Zhang, Runtong]的文章
[Pan, Yingmin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。